A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults
Clinical trial NCT06742281 · COMPLETED
Trial details
- NCT number
- NCT06742281
- Sponsor
- CyanVac LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-05
- Primary completion
- 2026-06-15
- Enrollment
- 432
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.